Xeris Biopharma Holdings, Inc. company logo
Xeris Biopharma Holdings, Inc. logo

Xeris Biopharma Holdings, Inc. (XERS) Cash From Investing

Annual CFI

$4.88M$10.89M+181.33%

Summary

Current Value
As of today, XERS annual cash from investing is $4.88M, up +181.33% on
Historical Performance
XERS annual cash from investing is down -95.02% over the past 3 years, and up +304.91% over the past 5 years
All-Time High Comparison
XERS annual cash from investing is currently -95.02% below its historical high of $97.96M set on
3-Year Low Comparison
XERS annual cash from investing is +181.33% above its 3-year low of -$6.00M reached on
Sector Comparison
XERS annual cash from investing is higher than 80.25% of companies in Healthcare sector

Cash From Investing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

XERS Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Investing$4.88M+181.3%-95.0%+304.9%+10000.0%
Quarterly Cash From Investing-$71.00K-100.7%-101.1%+99.9%+79.2%
TTM Cash From Investing$9.65M-0.8%-84.4%+122.1%+2922.5%
Price$7.21+115.2%+586.7%+24.3%
Annual Cash From Operations-$36.98M+21.4%+61.3%+64.6%-129.9%
Annual Cash From Financing$36.17M+2342.3%+32.7%-55.1%+826.4%
Annual CAPEX$868.00K-61.6%-20.0%-21.6%+2380.0%
Annual Free Cash Flow-$37.85M+23.2%+60.8%+64.1%-134.8%
Annual Total Assets$329.15M-3.4%+8.0%+202.0%+881.6%

Cash From Investing Highs

XERS Annual Cash From Investing Highs Comparison
PeriodHighDateCurrent
3Y$34.46MN/A-85.8%
5Y$97.96M-95.0%
All$97.96M-95.0%

Cash From Investing Lows

XERS Annual Cash From Investing Lows Comparison
PeriodLowDateCurrent
3Y-$6.00M+181.3%
5Y-$27.41MN/A+117.8%
All-$68.26M+107.2%

Cash From Investing History

YearValueChange
$4.88M+181.3%
-$6.00M-117.4%
$34.46M-64.8%
$97.96M+457.5%
-$27.41M-1,050.0%
YearValueChange
-$2.38M+96.5%
-$68.26M-9,651.6%
-$700.00K-1,900.0%
-$35.00K-

FAQ

  • What is the current annual cash from investing of XERS?

    As of today, XERS annual cash from investing is $4.88M

  • What is 1-year change in XERS annual cash from investing?

    XERS annual cash from investing is up +181.33% year-over-year

  • What is 3-year change in XERS annual cash from investing?

    XERS annual cash from investing is down -95.02% over the past 3 years

  • How far is XERS annual cash from investing from its all-time high?

    XERS annual cash from investing is currently -95.02% below its historical high of $97.96M set on December 31, 2021

  • How does XERS annual cash from investing rank versus sector peers?

    XERS annual cash from investing is higher than 80.25% of companies in Healthcare sector

  • When is XERS next annual earnings release?

    The next annual earnings release for XERS is on

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

Data Sources & References

  1. XERS Official Website www.xerispharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1867096/000186709625000159/0001867096-25-000159-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1867096/000186709625000039/0001867096-25-000039-index.htm
  4. XERS Profile on Yahoo Finance finance.yahoo.com/quote/XERS
  5. XERS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/xers